Personal Genome Diagnostics

Personal Genome Diagnostics enhances the fight against cancer by unlocking actionable information in the genome. We are committed to improving clinical insights, result speed, and healthcare economics by providing a portfolio of regulated tissue- and liquid-based genomic products to health systems worldwide. PGDx was founded by researchers from Johns Hopkins University, who are pioneers in cancer genome sequencing and liquid biopsy technology.